Robin H Lachmann

Title: The Innovations of Robin H Lachmann

Introduction

Robin H Lachmann is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of virology, particularly in the development of innovative viral constructs for therapeutic applications. His work focuses on utilizing herpes simplex virus technology to deliver sequences of interest to cells.

Latest Patents

Lachmann holds a patent for a "Replication defective herpes simplex virus comprising heterologous inserts." This invention involves constructs that utilize a herpes virus latency active promoter (LAP) from the latency associated transcript (LAT) region. The design includes an internal ribosome entry site (IRES) located downstream of the LAP, with a nucleotide sequence of interest positioned downstream of the IRES. This innovative approach allows for stable, long-term expression, including the export of mRNA to the cytoplasm and translation of the encoded polypeptide in both neuronal and non-neuronal cells. He has 1 patent to his name.

Career Highlights

Lachmann is associated with Cambridge University Technical Services Limited, where he continues to advance his research and development efforts. His work has implications for gene therapy and the treatment of various neurological conditions.

Collaborations

One of his notable collaborators is Stacey Efstathiou, with whom he has worked on various projects related to his patent.

Conclusion

Robin H Lachmann's innovative work in the field of virology exemplifies the potential of using viral constructs for therapeutic purposes. His contributions continue to pave the way for advancements in medical science.